Modern Synthesis raises $5.5m to expand biomaterials platform

Modern Synthesis has secured $5.5 million in a Seed 2 funding round led by Extantia Capital, with participation from Artesian and Collaborative Fund. This financing will enable the company to enhance production capabilities and address the demand from brands on its waitlist, particularly in the fashion sector.

Original excerpt: Modern Synthesis—a London-based startup developing biomaterials for high-end fashion brands—has closed a $5.5 million round led by Extantia Capital…

Source: AgFunderNews